Related Experiment Video
Updated: Nov 9, 2025

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
Published on: January 29, 2014
Detection of C3 Nephritic Factor by Hemolytic Assay
Melchior Chabannes1, Véronique Frémeaux-Bacchi1,2, Sophie Chauvet3,4
1INSERM, UMR_S 1138, Inflammation, Complement and Cancer Team, Centre de Recherche des Cordeliers, Sorbonne Universités, Université de Paris, Paris, France.
C3 nephritic Factor (C3NeF) stabilizes the C3 convertase enzyme. Hemolytic assays using sheep erythrocytes characterized C3NeF function, aiding complement system research.
Area of Science:
- Immunology
- Complement System Biology
Background:
- C3 nephritic Factor (C3NeF) is an autoantibody targeting the C3 convertase enzyme C3bBb.
- C3NeF stabilizes C3 convertase activity by binding to neoepitopes.
Purpose of the Study:
- To functionally characterize C3NeF using hemolytic assays.
- To explore the alternative pathway of complement activation.
Main Methods:
- Utilized hemolytic assays with pre-activated sheep erythrocytes.
- Employed rabbit anti-sheep red blood cell stroma antibody (hemolysin) for complement activation.
- Leveraged sheep erythrocytes sensitized with C3b to study alternative pathway dynamics.
Main Results:
- Established a method for functional C3NeF characterization.
- Demonstrated the role of sensitized sheep erythrocytes in exploring complement alternative pathway.
- Provided insights into the decay of the alternative pathway C3 convertase.
Conclusions:
- Hemolytic assays with C3b-bearing sheep erythrocytes are effective for C3NeF functional studies.
- This methodology facilitates research into complement alternative pathway regulation and C3NeF activity.
More Related Videos
09:43Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
07:52Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
Published on: September 10, 2018